Male and female WT and CD118-/- mice (6-10 weeks of age) were anesthetized by i.p. injection with xylazine (6.6 mg/kg) and ketamine (100 mg/kg) followed by scarification of the cornea using a 25 5/8-gauge needle. The tear film was then blotted, and the cornea was topically inoculated with 1,000 PFU of HSV-1 in 3 μl of RPMI-1640 medium. HSV-1 viral titers were determined in the designated tissue at times post infection (pi) by plaque assay as previously described (32 (link)).
>
Chemicals & Drugs
>
Amino Acid
>
LIFR protein, human
LIFR protein, human
LIFR (Leukemia Inhibitory Factor Receptor) is a transmembrane protein that serves as a receptor for the cytokine leukemia inhibitory factor (LIF).
It plays a crucial role in signal transduction pathways that regulate cell growth, differentiation, and survival.
LIFR is expressed in a variety of cell types and is involved in processes such as embryonic development, hematopoiesis, and neural function.
Reserach on LIFR protein has implications for understanding and treatingmany human diseases, including cancer, inflamatory disorders, and neurodegenerative conditions.
PubCompare.ai is an innovative AI-driven platform that can enhance the reproducibility and accuracy of LIFR protein research by helping scientists quickly locate the most reliable protocols from literature, preprints, and patents, while providing intelligent comparisons to identify the best approaches and products.
It plays a crucial role in signal transduction pathways that regulate cell growth, differentiation, and survival.
LIFR is expressed in a variety of cell types and is involved in processes such as embryonic development, hematopoiesis, and neural function.
Reserach on LIFR protein has implications for understanding and treatingmany human diseases, including cancer, inflamatory disorders, and neurodegenerative conditions.
PubCompare.ai is an innovative AI-driven platform that can enhance the reproducibility and accuracy of LIFR protein research by helping scientists quickly locate the most reliable protocols from literature, preprints, and patents, while providing intelligent comparisons to identify the best approaches and products.
Most cited protocols related to «LIFR protein, human»
Biological Assay
Cornea
Females
Human Herpesvirus 1
Infection
Ketamine
Laceration
LIFR protein, human
Males
Mice, House
Needles
Senile Plaques
Tissues
Xylazine
GIPZ lentiviral LIFR- and STAT3-targeting human shRNAs were purchased from Open Biosystems (catalog numbers in parentheses). LIFR shRNA #1=V2LHS_133981 (RHS4430-200216162), shRNA #2=V2LHS_133982 (RHS4430-200175346), shRNA #3=V3LHS_347493 (RHS4430-200297260). STAT3 shRNA = V2LHS_88502 (RHS4430-200162926), V3LHS_376016 (RHS4430-200250657), V3LHS_376018 (RHS4430-200248312), V3LHS_641817 (RHS4430-200225068), V3LHS_641818 (RHS4430-200227569), V3LHS_641819 (RHS4430-200223545). GIPZ vectors were transfected into 293T cells using Lipofectamine Plus (Life Technologies) to generate lentivirus, which was then transferred onto MCF7 or SUM159 cells. Breast cancer cells were selected for 6 days in 1μg/ml puromycin and evaluated for knockdown at the protein and mRNA level. ON-TARGETplus SMARTpool siRNAs for HIF1A (L-004018-00), EPAS1 (HIF2A) (M-004814-01), SETDB1 (L-020070-00), HDAC2 (L-003495-02), and SOCS3 (L-004299-00) were purchased from Dharmacon/GE Healthcare (catalog numbers in parentheses) along with ON-TARGETplus SMARTpool siControl (D-001810-10-20) and transfected into MCF7 or SUM159 cells using DharmaFECT 1 transfection reagent (Dharmacon/GE Healthcare).
Breast Carcinoma
Cells
Cloning Vectors
endothelial PAS domain protein 1, human
HEK293 Cells
HIF1A protein, human
Homo sapiens
Lentivirus
LIFR protein, human
Lipofectamine
MCF-7 Cells
Proteins
Puromycin
RNA, Messenger
RNA, Small Interfering
SETDB1 protein, human
Short Hairpin RNA
STAT3 protein, human
Transfection
Calu-3 and MDCK cells (ATCC) were maintained in minimum essential media supplemented with 10% fetal bovine serum and Dulbecco's modified Eagle's media with 5% fetal bovine serum, respectively [26] . Human pBECs were obtained from healthy individuals by endobronchial brushing during fibre-optic bronchoscopy [67] (link). Subjects had no history of smoking or lung disease and had normal lung function. All subjects gave written consent. pBEC were cultured as described [26] , [35] (link). For differentiation of pBECs, cells were grown on transwells (Corning) at air-liquid interface, with basolateral media changed every second day at 37°C/5% CO2[68] (link).
H3N2 and H5N1 were diluted in the appropriate serum free media and added to cells at multiplicity of infection (MOI) of 5 and of 0.005, respectively. After 1 h of incubation, the inocula were removed and replaced with serum-free media. Cells were treated with exogenous polyinosinic∶polycytidylic acid (Poly I:C, 100 µg/ml, Sigma-Aldrich), a known agonist of RIG-I and IFN responses, as a positive control [36] (link), [69] (link). Cycloheximide (100 ug/ml, Sigma-Aldrich) was used to inhibit protein synthesis by pre-treatment of cells (30 min, 37°C, 5% CO2) and was added to media after virus inoculation. Caspases inhibitor Z-DEVD-fmk (Calbiochem, USA) of 50 µM was used to pre-treat the cells for 3 h before infection and was added after 1 hr virus inoculation. In experiments involving the blockade of IFNAR2, cells were incubated with 1 µg/ml of mouse monoclonal neutralizing antibody to IFNAR2 (CD118, PBL Laboratories) for 1 h prior to virus inoculation.
H3N2 and H5N1 were diluted in the appropriate serum free media and added to cells at multiplicity of infection (MOI) of 5 and of 0.005, respectively. After 1 h of incubation, the inocula were removed and replaced with serum-free media. Cells were treated with exogenous polyinosinic∶polycytidylic acid (Poly I:C, 100 µg/ml, Sigma-Aldrich), a known agonist of RIG-I and IFN responses, as a positive control [36] (link), [69] (link). Cycloheximide (100 ug/ml, Sigma-Aldrich) was used to inhibit protein synthesis by pre-treatment of cells (30 min, 37°C, 5% CO2) and was added to media after virus inoculation. Caspases inhibitor Z-DEVD-fmk (Calbiochem, USA) of 50 µM was used to pre-treat the cells for 3 h before infection and was added after 1 hr virus inoculation. In experiments involving the blockade of IFNAR2, cells were incubated with 1 µg/ml of mouse monoclonal neutralizing antibody to IFNAR2 (CD118, PBL Laboratories) for 1 h prior to virus inoculation.
Antibodies, Neutralizing
benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone
Bronchoscopy
Cardiac Arrest
Caspase Inhibitors
Cells
Culture Media, Serum-Free
Cycloheximide
DDX58 protein, human
Fetal Bovine Serum
Homo sapiens
Infection
Influenza in Birds
LIFR protein, human
Lung Diseases
Madin Darby Canine Kidney Cells
Monoclonal Antibodies
Mus
Poly I-C
Protein Biosynthesis
Respiratory Physiology
Viral Vaccines
Ba/F3-gp130 cells were retrovirally transduced with the retroviral expression plasmids derivatives of pMOWS and pMOWS-hygromycin. pMOWS-IL-15-gp130, pMOWS-IL-15-WSX-1, pMOWS-IL-15-LIFR, pMOWS-IL-15-OSMR, as well as pMOWS-hygromycin-IL-15Rα-sushi-gp130, pMOWS-hygromycin-IL-15Rα-sushi-WSX-1 or pMOWS-hygromycin-IL-15Rα-sushi-GPL, pMOWS-FUSIO and the control vector pMOWS-GFP or pMOWS-hygromycin-GFP (5 μg each) were transiently transfected in 8 × 105 Phoenix-Eco cells using Lipofectamine 2000 according to manufacturer's instructions (Invitrogen). The transfection efficiency was typically ∼50%, which was estimated by green fluorescent protein (GFP) expression 24 h after transfection (Axiovert 200 microscope, Zeiss, Jena, Germany). Retroviral supernatants were produced as described (Ketteler et al., 2002 (link)). Retroviral supernatant, 250 μl, was applied to 1 × 105 Ba/F3-gp130 cells and mixed, and the solution was centrifuged at 1800 rpm for 2 h at 25°C. Transduced cells were grown in standard medium supplemented with 10 ng/ml Hyper-IL-6. Forty-eight hours after transduction, transduced Ba/F3-gp130 cells were selected in 1.5 μg/ml puromycin and/or 1 mg/ml hygromycin (PAA Laboratories) for at least 2 wk. After 2 wk of antibiotic selection, Hyper-IL-6 was washed away and the cells were screened for cytokine-independent growth.
Antibiotics
Cells
Cytokine
derivatives
fusio
Green Fluorescent Proteins
hygromycin A
IL6ST protein, human
Interleukin-10
Interleukin-15
LIFR protein, human
lipofectamine 2000
Microscopy
OSMR protein, human
Plasmids
Puromycin
Retroviridae
Transfection
Animals
Animals, Laboratory
Glycoproteins
Human Herpesvirus 1
Interferon Type I
LIFR protein, human
Mice, Laboratory
Mice, Transgenic
Strains
Most recents protocols related to «LIFR protein, human»
8-week old female mice in diestrus were perfused with ice cold PBS, brains rapidly removed and flash frozen in isopentane on dry ice. Coronal brain sections of 500 μm were obtained using vibratome, hypothalamus dissected, RNA isolated using the RNAqueous®-Micro Kit (Ambion) and quantified using Nanodrop. Gene expression in 50 ng RNA per sample was analyzed using the Nanostring instrument as described before (54 (link)), according to manufacturer’s instruction, with the nCounter Mouse Neuroinflammation Panel (770 genes, gene list available at the manufacturer’s website). The panel was customized with an addition of 30 custom probes for: Gnrh1, Kiss1, Kiss1r, Pdyn, Tac2, Tac3r, Agrp, Npy, Pomc, Cart, Mc3r, Mc4r, Hcrt, Ghrh, Crh, Trh, Oxt, Avp, Prl, Prlr, Adcyap1, Slc6a3, Slc32a1, Slc17a6, Th, Lif, Lifr, Gabra5, Gabra1, Gabrg2. Only samples with an RNA integrity number RIN over 7 were used after passing QC, with no imaging, binding, positive control, or CodeSet content normalization flags. Data analysis was performed using nSolver Analysis Software 4.0, including nCounter Advanced Analysis (version 2.0.115). Genes with the expression lower than the limit of detection after background subtraction, and compared to negative controls included in the panel, were excluded. Seven housekeeping control genes that are included in the panel, were used for normalization. A heatmap of differentially expressed genes (DEG) was created using Heatmapper software from University of Alberta (Edmonton, Canada (55 (link));). Results are plotted in the Volcano plot as log fold change vs. log p-value, and genes with changes higher than 20% were indicated with colors in the figures: red indicates genes higher in KO compared to WT, while green indicates genes that are higher in the WT compared to KO. Genes with significant changes in expression are indicated above the dashed line. Gene ontology (GO) enrichment analysis of the DEG genes was performed using the ShinyGo 0.76.3 platform (South Dakota State University (56 (link))). False discovery rate (FDR) cutoff was 0.05, with the pathway minimum set to 10. Data is deposited in GEO repository (accession number GSE222723).
AGRP protein, human
Brain
CART protein, human
Cold Temperature
Diestrus
Dry Ice
Females
Freezing
Gene Expression
Genes
Genes, Housekeeping
Genes, vif
GHRH protein, human
HCRT protein, human
Hypothalamus
isopentane
KISS1 protein, human
LIFR protein, human
MC4R protein, human
Mice, Laboratory
PTP4A3 protein, human
Receptors, Kisspeptin-1
SLC6A3 protein, human
Transcription, Genetic
Whole cell lysates were produced by rinsing cells grown on culture plates twice with PBS, prior to scraping the cells into a small volume of PBS. Cells were pelleted by centrifugation at 300 × G in microcentrifuge tubes, and an appropriate amount of RIPA lysis buffer (50 mM Tris-Cl, pH 7.6, 1% NP-40, 12 mM sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 165 mM sodium chloride) was added. The cells were kept on ice with occasional mixing for ~45 min and then centrifuged at 16,000 × G at 4°C for ten minutes. The supernatants were then transferred into fresh tubes and stored at −20°C. Protein concentrations were measured using a Pierce Micro BCA Protein Assay Kit (Thermo Fisher Scientific). Samples were denatured by adding an appropriate volume of Laemmli sample buffer (62.5 mM Tris-Cl pH 6.8, 1% SDS, 10% glycerol, 50 mM dithiothreitol (DTT), 0.001% bromophenol blue), followed by incubation at 95°C for 5 min. Denatured samples were resolved by electrophoresis through polyacrylamide gels ranging from 7.5% to 12.5% and electrotransferred onto polyvinylidene fluoride (PVDF) membranes at a constant current for 16–20 hours. Membranes were incubated in blocking buffer (5% skim milk in Tris-buffered saline with 0.01% Tween-20, TBST) for one hour at room temperature (RT), and then incubated for 2–24 hours at 4°C in blocking buffer with the addition of a primary antibody to detect the protein of interest. The following primary antibodies were used: LIFR (Santa Cruz #sc -515,337), FAM3C (Sigma #AV44904), pSTAT3 (Cell Signaling #9145), STAT3 (Cell Signaling #9139), GAPDH (Santa Cruz #sc -32,233), β-Actin (Santa Cruz #sc -47,778), TWIST1 (Cell Signaling #90445), and HSP90 (Santa Cruz #sc -13,119). After primary antibody incubation, the membranes were rinsed 3 X 10–15 minutes in TBST and then incubated in blocking buffer with the addition of the appropriate secondary antibody for 0.5–1.5 hours at RT. The following horseradish peroxidase (HRP)-conjugated secondary antibodies were used: goat anti-mouse IgG (Thermo Fisher #31430; 1:10,000) and goat anti-rabbit IgG (Thermo Fisher #31460; 1:10,000). After incubation with the secondary antibody, the membranes were washed again as described above. Bands were detected by adding 1–2 mL of HRP substrate (EMD Millipore) directly onto the membrane. Images were acquired using ChemiDoc MP (Bio-Rad) and processed using Image Lab software (Bio-Rad).
Actins
anti-IgG
Antibodies
Antibodies, Blocking
Biological Assay
Bromphenol Blue
Buffers
Cells
Centrifugation
Deoxycholic Acid, Monosodium Salt
Dithiothreitol
Electrophoresis
GAPDH protein, human
Glycerin
Goat
Horseradish Peroxidase
HSP90 Heat-Shock Proteins
Immunoglobulins
Laemmli buffer
LIFR protein, human
Milk, Cow's
Mus
Nonidet P-40
polyacrylamide gels
polyvinylidene fluoride
Proteins
Rabbits
Radioimmunoprecipitation Assay
Saline Solution
Sodium Chloride
STAT3 Protein
Sulfate, Sodium Dodecyl
Tissue, Membrane
Tween 20
TWIST1 protein, human
A DNA sequence corresponding to the mouse LIFR regulatory region (Table S3) was amplified from genomic DNA extracts and ligated into the pGL3-Basic vector (Promega). Approximately 100 K cells in 12-well culture plates were co-transfected with ~1 µg pGL3 and ~ 500 ng pNL3.1 (Promega) and allowed to grow for 24 h. The cells were then trypsinized and resuspended in DMEM containing 10% serum, centrifuged at 300 × G and washed 2X with PBS with repeated centrifugation. Cells were then resuspended in 200 µL of PBS and distributed into 96-well opaque white assay plates (triplicate wells at 60 µL). Luminescence was measured using the Nano-Glo Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer’s protocol using a Molecular Devices Spectramax iD5 Multi-Mode Microplate Reader. The relative normalized reporter signal was calculated by first subtracting “background signal” firefly luminescence (pGL3) acquired from pGL3-Basic “empty vector” control transfections from each experimental transfection, then dividing the remaining firefly luminescence values by the Nano-Luc luminescence (pNL3.1) values generated by the same well to determine the normalized reporter signal per well. Finally, the mean normalized reporter signal was determined from triplicate wells and compared between experimental groups. For experiments using the STAT3 CIE reporter, the pGL3 vector was replaced with the pGL4.47 vector (Promega). For experiments using STAT3 inhibition, the cells were seeded in DMEM and allowed to grow overnight. Immediately prior to transfection, the culture medium was replaced with a medium containing STAT3-IN-1 (10 µM final concentration) or an equal volume of DMSO.
Biological Assay
Cell Culture Techniques
Cells
Centrifugation
Cloning Vectors
DNA, A-Form
Fireflies
Genome
LIFR protein, human
Luciferases
Luminescence
Medical Devices
Mus
Paragangliomas 3
Paragangliomas 4
Promega
Psychological Inhibition
Regulatory Sequences, Nucleic Acid
Serum
STAT3 Protein
Sulfoxide, Dimethyl
Transfection
The following antibodies were used for detection by flow cytometry as previously described [22 (link)]: LIFR, gp130, PD-L1, and detection of activation markers was performed similarly using the conjugated antibodies CD14-APC, CD16-APC, CD150-APC, and CD163-APC (Table S1 ).
For the detection of intracellular JunB and Iba-1, microglia cells were fixed with methanol for 20 min at −20 °C, then washed twice with RPMI 1640 supplemented with 10% FCS, and processed as previously described [17 (link)].
Antigen expression was determined using an S100EXi flow cytometer (Stratedigm, Inc., San Jose, CA, USA) with CellCapTure software v4.1 (https://stratedigm.com/cellcapture/ accessed on 5 February 2023) (Stratedigm, Inc.) and FlowJo v10 (FlowJo, Ashland, OR, USA). Dead cells were gated out from the analysis.
For the detection of intracellular JunB and Iba-1, microglia cells were fixed with methanol for 20 min at −20 °C, then washed twice with RPMI 1640 supplemented with 10% FCS, and processed as previously described [17 (link)].
Antigen expression was determined using an S100EXi flow cytometer (Stratedigm, Inc., San Jose, CA, USA) with CellCapTure software v4.1 (
Antibodies
Antigens
CD163 protein, human
CD274 protein, human
Cells
Flow Cytometry
IL6ST protein, human
LIFR protein, human
Methanol
Microglia
Protoplasm
signaling lymphocytic activation molecule, human
For protein expression analysis in microglia, microglia cells were starved with a mixture of RPMI 1640 and Prigrow III culture media (1:1) supplemented with 0.5% FCS for 1 h prior to treatment with melanoma-conditioned medium (MCM) or with recombinant cytokines. For experiments employing signaling pathway inhibitors or LIF receptor (LIFR) inhibitor, EC359 (HY-120142, MedChemExpress, Monmouth Junction, NJ, USA), microglia cells were starved with the relevant inhibitor (diluted in DMSO) or with DMSO, as control, for 1 h, prior to treatment with MCM.
Protein detection by Western blot was performed as previously described [6 (link)]. Primary Abs against the following proteins were used: JunB, phospho-STAT3 (Tyr705), STAT3, OSM, and anti-β-tubulin (loading control) (Table S1 ). Horseradish peroxidase-conjugated goat anti-mouse or goat anti-rabbit (1:10,000, Jackson ImmunoResearch Laboratories, West Grove, PA, USA) was used as secondary Abs. The bands were visualized by chemiluminescence ECL reactions (Merck Millipore, Darmstadt, Germany), and band density was quantified by Quantity One® software v4.6.6 (Bio-Rad Laboratories).
Protein detection by Western blot was performed as previously described [6 (link)]. Primary Abs against the following proteins were used: JunB, phospho-STAT3 (Tyr705), STAT3, OSM, and anti-β-tubulin (loading control) (
Chemiluminescence
Culture Media
Culture Media, Conditioned
Cytokine
Goat
Horseradish Peroxidase
inhibitors
LIFR protein, human
Melanoma
Microglia
Mus
Proteins
Rabbits
Signal Transduction
STAT3 protein, human
Sulfoxide, Dimethyl
Tubulin
Western Blot
Top products related to «LIFR protein, human»
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
Sourced in United States, China, Germany, Japan, United Kingdom, France, Canada, Italy, Australia, Switzerland, Denmark, Spain, Singapore, Belgium, Lithuania, Israel, Sweden, Austria, Moldova, Republic of, Greece, Azerbaijan, Finland
Lipofectamine 3000 is a transfection reagent used for the efficient delivery of nucleic acids, such as plasmid DNA, siRNA, and mRNA, into a variety of mammalian cell types. It facilitates the entry of these molecules into the cells, enabling their expression or silencing.
Recombinant human LIF is a cytokine that promotes the self-renewal of undifferentiated embryonic stem cells. It is produced in a human cell expression system.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, China, Germany, United Kingdom, Switzerland, Japan, France, Italy, Spain, Austria, Australia, Hong Kong, Finland
The Dual-Luciferase Reporter Assay System is a laboratory tool designed to measure and compare the activity of two different luciferase reporter genes simultaneously. The system provides a quantitative method for analyzing gene expression and regulation in transfected or transduced cells.
Sourced in United States
Sc-659 is an antibody product manufactured by Santa Cruz Biotechnology. It is a mouse monoclonal antibody that can be used for research purposes.
Sourced in United States, United Kingdom, Germany, Switzerland, Canada, Belgium, China, Sweden, Japan
Accutase is a cell detachment solution designed for the gentle dissociation of adherent cells. It contains a mixture of proteolytic and collagenolytic enzymes that effectively disrupt cell-cell and cell-matrix adhesions, allowing for the easy harvesting and passaging of a variety of cell types.
Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.
Sourced in United States, Japan, China, Germany, United Kingdom, Switzerland, Canada, Singapore, Italy, France, Belgium, Denmark, Spain, Netherlands, Lithuania, Estonia, Sweden, Brazil, Australia, South Africa, Portugal, Morocco
The StepOnePlus Real-Time PCR System is a compact, flexible, and easy-to-use instrument designed for real-time PCR analysis. It can be used to detect and quantify nucleic acid sequences.
Sourced in United States
EC359 is a laboratory equipment product manufactured by MedChemExpress. It functions as a centrifuge, a device used to separate and concentrate materials of different densities within a liquid solution through the application of centrifugal force.
More about "LIFR protein, human"
Leukemia Inhibitory Factor Receptor (LIFR) is a transmembrane protein that serves as a receptor for the cytokine leukemia inhibitory factor (LIF).
It plays a crucial role in signal transduction pathways that regulate cell growth, differentiation, and survival.
LIFR is expressed in a variety of cell types and is involved in processes such as embryonic development, hematopoiesis, and neural function.
Research on LIFR protein has implications for understanding and treating many human diseases, including cancer, inflammatory disorders, and neurodegenerative conditions.
Scientists studying LIFR can utilize various tools and reagents to enhance their research, such as Lipofectamine 2000 and Lipofectamine 3000 for efficient transfection, Recombinant human LIF for cell culture experiments, TRIzol reagent for RNA extraction, Dual-Luciferase Reporter Assay System for gene expression analysis, Sc-659 for LIFR signaling studies, Accutase for cell detachment, RNeasy Mini Kit for RNA purification, and StepOnePlus Real-Time PCR System for quantitative gene expression analysis.
The AI-driven platform PubCompare.ai can further enhance the reproducibility and accuracy of LIFR protein research by helping scientists quickly locate the most reliable protocols from literature, preprints, and patents, while providing intelligent comparisons to identify the best approaches and products.
Exploring the role of LIFR in cellular processes and its implications for human health can lead to advancements in the understanding and treatment of various diseases, such as cancer, inflammatory conditions, and neurodegenerative disorders.
The availability of specialized tools and the innovative PubCompare.ai platform can streamline and optimize LIFR protein research, ultimately contributing to the development of more effective therapies and improved patient outcomes.
It plays a crucial role in signal transduction pathways that regulate cell growth, differentiation, and survival.
LIFR is expressed in a variety of cell types and is involved in processes such as embryonic development, hematopoiesis, and neural function.
Research on LIFR protein has implications for understanding and treating many human diseases, including cancer, inflammatory disorders, and neurodegenerative conditions.
Scientists studying LIFR can utilize various tools and reagents to enhance their research, such as Lipofectamine 2000 and Lipofectamine 3000 for efficient transfection, Recombinant human LIF for cell culture experiments, TRIzol reagent for RNA extraction, Dual-Luciferase Reporter Assay System for gene expression analysis, Sc-659 for LIFR signaling studies, Accutase for cell detachment, RNeasy Mini Kit for RNA purification, and StepOnePlus Real-Time PCR System for quantitative gene expression analysis.
The AI-driven platform PubCompare.ai can further enhance the reproducibility and accuracy of LIFR protein research by helping scientists quickly locate the most reliable protocols from literature, preprints, and patents, while providing intelligent comparisons to identify the best approaches and products.
Exploring the role of LIFR in cellular processes and its implications for human health can lead to advancements in the understanding and treatment of various diseases, such as cancer, inflammatory conditions, and neurodegenerative disorders.
The availability of specialized tools and the innovative PubCompare.ai platform can streamline and optimize LIFR protein research, ultimately contributing to the development of more effective therapies and improved patient outcomes.